BRIDGEBIO PHARMA INC - NOTE 2.250% 2/0

Historical Portfolio Holders from Q1 2022 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Debt / NOTE 2.250% 2/0
Principal, excl. options Q3 2024
632M
Holdings value Q3 2024
$532M
Value change Q3 2024
-$6.33M
Grand Portfolio weight change Q3 2024
0%
Number of holders
38
Number of buys Q3 2024
15
Number of sells Q3 2024
-17
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $632M $532M -$6.33M $0.84 38
2024 Q2 $642M $515M -$52.5M $0.80 42
2024 Q1 $625M $545M -$20.6B $0.82 43
2023 Q4 $644M $548M +$26.5M $0.85 40
2023 Q3 $616M $465M +$90.2M $0.75 44
2023 Q2 $503M $312M -$2.52M $0.62 40
2023 Q1 $516M $332M +$5.38M $0.64 43
2022 Q4 $536M $207M -$1.33M $0.38 34
2022 Q3 $491M $223M -$37.9M $0.44 32
2022 Q2 $595M $254M -$25.4M $0.41 34
2022 Q1 $625M $311M +$310M $0.48 36